Four views: Future prospects for the weight-loss sector
Portfolio Adviser asks this month’s panel for their views on the future prospects for a healthcare sector that seems to be booming
Novo Nordisk
-
-
WHEB’s Kluftinger: The weight loss industry is a megatrend in the making
Obesity drugs are at a revolutionary moment comparable to the launch of the iPhone, writes Ben Kluftinger
-
FundCalibre’s McDermott: Anti-obesity drugs will drive healthcare in 2024
Demand for GLP-1 medications is skyrocketing
-
BlackRock appoints Alexandra Dangoor as Greater Europe co-portfolio manager
Dangoor to work alongside Stefan Gries
